OxiStat Plus Presentation [ ~ 9422kb ]
Transcription
OxiStat Plus Presentation [ ~ 9422kb ]
\ Nowadays population +65 is 506million \ 2008 – 2020: world population increase by 14% + 35 years increase 26% + 65 years increase 43% \ Elderly population mostly in developed countries OXIDATIVE STRESS Antioxidants O2 Free Radicals Oxidative stress imbalance leads to premature aging. BioPower Labs: \ clinical analysis service provider \ anti-aging personalized medicine analysis C:\Users\Renata Blatt\Desk top\Fotolia_3862041_X S .j p g + [ 1st stage ] + [ 2nd stage ] Oxistat Plus Report – Oxidative Stress Status Name Age Gender Weight Height John Smith 38 Male 80 Kg 1,75 m Analyzed parameters Results Reference Values Track Record Observations Beta‐galactosidase 79 * ‐ Early senescence signs GSH/GSSG 30 41‐79µg/l ‐ Not depleted Gamma‐ glutamylcysteine SOD‐1 13 12‐43 U/l ‐ ‐ 55 14‐36 U/l ‐ ‐ Catalase 60 9‐52 U/l ‐ ‐ NADH dehydrogenase 125 38‐126 U/l ‐ ‐ Cytochrome oxidase 42 14‐36 U/l ‐ ‐ p53 80 * ‐ ‐ Oxi‐LDL 1781 1370±427 nmol/L ‐ ‐ Total ROS 325 * ‐ ‐ *age dependent (see appendix) Healthy Unhealthy Oxidative Stress Scale Low 5 5 Medium High Value corresponding to a patient with decreased antioxidant defenses due to genetic predisposition and/or lifestyle. This value may be improved with dietary changes and supplement intake. \ Market size: 985k units - 250 M€ (2007) \ Rate of growth: 20% per year 525k units 79k units 151k units SOURCES: GENOVA DIAGNOSTICS, INTERLEUKIN, A4M, SBME,. USA \ Genelex \ Interleukin Genetic Analysis Labs \ Integrative Genomics BIOCHEMICAL TESTING \ Sciona USA and Europe \ Genova Diagnostics Europe \ Genosolutions CUSTOMERS (PRIVATE PRACTICE): • Cellulemblock • Porto Nutrition Clinic • Persona • Corporation Dermoestética •… Innovator First Mover \ Innovator » new technology / new type of diagnostic results. \ First Movers » adding value in the anti-aging market. Private Clinics Upper Middle Class Hypochondri ac BioPower Labs Hospitals* Chronical* Diseases Club Medical Department Competition Athletes *Health Plan Program End Consumer MEDICAL AESTHETIC CLINICS » medical staff« endocrinologist nutritionists dermatologist HOSPITALS SPORT MEDICAL DEPARTMENTS CRO OTHER PLATFORM APPLICATIONS Ex: Corporation Dermoestetica; CelullemBlock; Persona Entry Market Expansion Market END CONSUME R * Medical Aesthetic Clinics: \ Number of clinics: ~6500 (Europe; North America; Brazil) SELLING FEATURES: •Unique measurement tool • Easy and simple measurement scale to use and read •Personalized medicine tool 1 week Client & Physicians BioPower KIT: Antioxidan Antioxidan t t SAMPLES SAMPLES \ Commercialization strategy: mainly through our intermediates through the establishment of partnerships in the area of clinical and aesthetics players . \ Brochure may be customized to indicate recommended treatments. PATENT Oxistat Plus Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 OXISTAT Clinical Testing Scale Set-up OXISTAT PLUS Expansion Market 500 k€ investment 2 M€ investment Year 7 Year 8 Scientific & Advisory Board Oxista t Plus \ Funding: 2,5 Million Euros, divided into 2 rounds \ Payback: 4 years by Technologist 9Catarina Gonçalves MBA’s 9 António Fernandes 9 Catarina Maia 9 Renata Blatt Advisor 9 Eduardo Teixeira de Sousa